XML 50 R23.htm IDEA: XBRL DOCUMENT
v3.20.4

3. RESEARCH AND DEVELOPMENT EXPENSES (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2020
Research and Development [Abstract] |
Research and Development expenses | Our research and development expenses in those periods were as follows:
|  |  | December 31, |  |  | December 31, |
|  |  | 2020 |  |  | 2019 |
Three months ended |  |  | $ | 461,176 |  |  | $ | 218,571 |
Nine months ended |  |  | $ | 1,367,333 |  |  | $ | 692,022 |

X
- References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature and amounts of capitalized costs of a research and development nature that were acquired in a transaction other than a business combination, the amount of such assets charged to expense during the period, and identification of the income statement caption in which the charges are included. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration